Gunter Thomas

This inventor holds 25 USPTO granted patents, primarily in Dihydropyridine Derivatives. Top assignee: Bayer Aktiengesellschaft. Active years: 1982-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gunter Thomas. Retrieved from https://idiyas.com/inventor/gunter-thomas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 25

% Patents Active = 100.0

Average Co-Inventor Count = 5.4

ph-index = 7

Forward Citations = 253(Granted Patents)

Location History:

Milan, IT (1987)
Garbagnate, IT (1988)
Wuppertal, DE (1982 - 2001)

Company Filing History:

25 out of 12,269

Bayer Aktiengesellschaft

patents

Years Active: 1982-2001

Loading Chart...

Areas of Expertise:

Dihydropyridine

Circulation-Active

Vaso-Dilating

Chromone

Thiochromone

Nitrodihydropyridine

Inotropic Activity

Carboxamide

Pyrimidine

Bioactive Compounds

Coronary Diseases

Optically Active

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6174884 - 1,5-dihydro-pyrazolo[34-D]-pyrimidinone derivatives (2001-01-16),

2. 4895855 - Mixture of different dihydropyridines (1990-01-23),

3. 4822798 - Circulation-active 4-phenyl-6-substituted dihydropyrimidines (1989-04-18),

4. 4791122 - Circulation active novel 5-aryldihydropyridines (1988-12-13),

5. 4772612 - Circulation-active 1,4-dihydropyridines (1988-09-20),

6. 4772611 - Circulation-active 3-amino-dihydropyridines (1988-09-20),

7. 4764516 - Mixtures of optically active nitrodihydropyridines active on the (1988-08-16),

8. 4762853 - 1-oxo-1,3,4,7-tetrahydrobenzo[C]furans (1988-08-09),

9. 4710501 - Circulation active pyrimidinyl-dihydropyridines (1987-12-01),

10. 4707479 - Circulation active dihydropyridine-3-carboxamides (1987-11-17),

11. 4647568 - Circulation-active hydroxy-tetra-hydropyridinelactones (1987-03-03),

12. 4645775 - Positive inotropic 3-nitro-5-substituted ester and (1987-02-24),

13. 4642310 - Circulation-active tetrahydrothienopyridines (1987-02-10),

14. 4628107 - Intermediate 8-carboxaldehyde-(-chromone and -thiochromone) derivatives (1986-12-09),

15. 4621093 - Vaso-dilating and coronary active 4-nitrophenyl-tetrahydropyridines (1986-11-04),

Title: Gunter Thomas: Pioneering Innovation in Pharmaceutical Solutions

Introduction:

Gunter Thomas, a remarkable inventor based in Wuppertal, Germany, is a beacon of innovation, inspiring the next generation of inventors to think outside the box and create solutions that shape the future of technology. With a staggering number of 25 patents to his name, Gunter Thomas has established himself as a leading figure in the field of pharmaceutical inventions.

Latest Patents:

Among his latest patents, Gunter Thomas has introduced groundbreaking pharmaceutical compounds such as the 1,5-dihydro-pyrazolo[3,4-d]-pyrimidinone derivatives. These compounds are vital in medicaments for treating cardiovascular and cerebrovascular diseases, diseases of the peripheral blood vessels, and diseases of the urogenital tract. Additionally, his invention of a mixture of different dihydropyridines has proven to be effective in treating circulation disorders, showcasing his profound impact on the medical field.

Career Highlights:

Gunter Thomas currently lends his innovative expertise to Bayer Aktiengesellschaft, a renowned pharmaceutical company committed to advancing healthcare worldwide. His contributions to Bayer have been instrumental in developing cutting-edge pharmaceutical solutions that improve the lives of countless individuals globally.

Collaborations:

In his journey of innovation, Gunter Thomas collaborates closely with esteemed coworkers such as Matthias Schramm and Rainer Gross. Together, they form a formidable team dedicated to pushing the boundaries of pharmaceutical research and development.

Conclusion:

In conclusion, Gunter Thomas stands as a testament to the power of innovation and perseverance in the realm of inventions. His trailblazing work in pharmaceutical solutions not only underscores his individual brilliance but also serves as a source of inspiration for aspiring inventors worldwide. Gunter Thomas's impact on the field of technology and healthcare is truly profound, shaping a brighter and more innovative future for all.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]